3081 Molecular Tumor Board (MTB) in non-small cell lung cancers (NSCLC) to optimize targeted therapies: 4 years' experience at Gustave Roussy. (September 2015) - Planchard, D.; Faivre, L.; Sullivan, I.; Kahn-charpy, V.; Lacroix, L.; Auger, N.; Adam, J.; De Montpreville, V. Thomas; Dorfmuller, P.; Pechoux, C. Le; Chevalier, T. Le; Gazzah, A.; et al.